CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 8-K Event Results of operations
- 4 Open-market sale Director sold 10,000 shares at an average $126.43 ($1,264,348)
- 4 Open-market sale President sold 25,000 shares at $165.00 ($4,125,000)
- 4 Open-market sale Director sold 47,536 shares at an average $149.49 ($7,106,341)
- 4 Open-market sale Director sold 30,375 shares at an average $152.48 ($4,631,583)
- 4 Open-market sale President sold 25,000 shares at $156.55 ($3,913,750)
- 4 Open-market sale President sold 25,000 shares at an average $128.62 ($3,215,458)
- 4 Open-market sale Chief Executive Officer sold 30,000 shares at an average $126.43 ($3,792,804)
- 4 Open-market sale Director sold 10,000 shares at an average $126.61 ($1,266,118)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Regulation FD disclosure · Other events
- 4 Shares withheld for taxes Chief Executive Officer gave up 779 shares (to pay taxes)
Page 20 of 45 · 883 filings